Study shows 'feasibility' of ending specialist follow-up in patients with low-risk chronic lymphocytic leukemia

by American Society of HematologyCredit: CC0 Public DomainA study published inBlood Advancesshowed that among patients in Denmark who had slow-growing chronic lymphocytic leukemia (CL

Updated on: April 06,2024

Study shows 'feasibility' of ending specialist follow-up in patients with low-risk chronic lymphocytic leukemia

by American Society of HematologyCredit: CC0 Public DomainA study published inBlood Advancesshowed that among patients in Denmark who had slow-growing chronic lymphocytic leukemia (CL

Updated on:April 06,2024

Experts explain treatment options for a common cancer complication

byThe Endocrine SocietyOsteoclast formation, activity, and pharmacologic inhibition. (A) Osteoclasts develop from osteoclast precursor cells when receptor activator of nuclear factor κ B (RANK)

Updated on: January 22,2024

Experts explain treatment options for a common cancer complication

byThe Endocrine SocietyOsteoclast formation, activity, and pharmacologic inhibition. (A) Osteoclasts develop from osteoclast precursor cells when receptor activator of nuclear factor κ B (RANK)

Updated on:January 22,2024

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Updated on: March 20,2024

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Updated on:March 20,2024

New drug targets for BRCA-driven cancer uncovered

by Brigham and Women's HospitalCredit: CC0 Public DomainBRCA1 and BRCA2 ("BReast CAncer genes") are critical tumor suppressor genes—women carrying a mutation in one of these genes h

Updated on: March 30,2024

New drug targets for BRCA-driven cancer uncovered

by Brigham and Women's HospitalCredit: CC0 Public DomainBRCA1 and BRCA2 ("BReast CAncer genes") are critical tumor suppressor genes—women carrying a mutation in one of these genes h

Updated on:March 30,2024

Immune system boost could prevent lung cancer

by Sara Rimer,Boston UniversityIn this microscopic image of precancerous lung tissue, the hot pink cells are dividing faster than in normal lung tissue. Credit: Beane, et al.,Nature Commun

Updated on: April 18,2024

Immune system boost could prevent lung cancer

by Sara Rimer,Boston UniversityIn this microscopic image of precancerous lung tissue, the hot pink cells are dividing faster than in normal lung tissue. Credit: Beane, et al.,Nature Commun

Updated on:April 18,2024

Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

by National University of SingaporeThe components of the dosimeter fit into an 18mm by 7mm capsule, a common size for many supplements and medicines. Credit: National University of SingaporeGastr

Updated on: February 23,2024

Researchers invent novel ingestible capsule X-ray dosimeter for real-time radiotherapy monitoring

by National University of SingaporeThe components of the dosimeter fit into an 18mm by 7mm capsule, a common size for many supplements and medicines. Credit: National University of SingaporeGastr

Updated on:February 23,2024

Study finds non-Hodgkins lymphoma treatment also targets related forms of lymphoma

by Hudson Institute of Medical ResearchHelicobacter-infected Nlrc5mø-KOmice develop precursor lesions to gastric B-cell MALT lymphoma. Representative H&E-stained sections of gastric tis

Updated on: February 23,2024

Study finds non-Hodgkins lymphoma treatment also targets related forms of lymphoma

by Hudson Institute of Medical ResearchHelicobacter-infected Nlrc5mø-KOmice develop precursor lesions to gastric B-cell MALT lymphoma. Representative H&E-stained sections of gastric tis

Updated on:February 23,2024

The virtual cancer patient

by Technische Universitat DarmstadtIn the laboratory: Professor Heinz Koeppl (left) and his research associate Jascha Diemer. Credit: Katrin BinnerNo two cancers are the same. Each type of leukae

Updated on: March 01,2024

The virtual cancer patient

by Technische Universitat DarmstadtIn the laboratory: Professor Heinz Koeppl (left) and his research associate Jascha Diemer. Credit: Katrin BinnerNo two cancers are the same. Each type of leukae

Updated on:March 01,2024

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat

Updated on: March 14,2024

'Bet hedging' explains the efficacy of many combination cancer therapies

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rat

Updated on:March 14,2024

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre

Updated on: February 03,2024

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre

Updated on:February 03,2024

Thousands of cervical screening samples are waiting to be tested, says report

by Cancer Research UKCredit: CC0 Public DomainMore than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.A study fr

Updated on: March 08,2024

Thousands of cervical screening samples are waiting to be tested, says report

by Cancer Research UKCredit: CC0 Public DomainMore than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.A study fr

Updated on:March 08,2024

Researchers identify promising new target for drug-resistant breast and ovarian cancers

by Lisa Marshall, University of Colorado at BoulderGraphical abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.03.017CU Boulder researchers have discovered a protein's

Updated on: February 01,2024

Researchers identify promising new target for drug-resistant breast and ovarian cancers

by Lisa Marshall, University of Colorado at BoulderGraphical abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.03.017CU Boulder researchers have discovered a protein's

Updated on:February 01,2024